Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ArrowHead Pharma

ARWR

85.5300.08% ( -0.070 )

Closed: Jul 27, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

This General Motors Analyst Turns Bulish; Here Are Top 5 Upgrades For Monday
benzinga_article·19 hours ago
F-C-5.00%F-D+0.33%
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia | ARWR Stock News
StockTitan·1 day ago, 10:30 PM
ARWR-8.00%
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
rttnews·Jul 22 at 10:15 PM
ZCMD-12.14%DRIO-4.11%
Arrowhead Pharmaceuticals Inc Stock (ARWR) Closed Up by 19.04% on Jul 22: What Signal Does It Send?
TradingKey·Jul 22 at 03:17 PM
ARWR-8.00%
Chardan Capital Forecasts Strong Price Appreciation for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock
Market Beat·Jul 22 at 02:36 PM
ARWR-8.00%
Arrow Pharmaceuticals soars 22% on strong Phase 3 lipid drug results
US Stock Market Update·Jul 22 at 02:13 PM
ARWR-8.00%
Arrowhead Drug Shows Strong Efficacy In Cutting Blood Fat
benzinga_article·Jul 22 at 01:25 PM
ARWR-8.00%
Arrowhead Pharma Soars 22% as Plozasiran Hits Phase 3 Endpoint
US Stock Market Update·Jul 22 at 11:20 AM
ARWR-8.00%
CME Group, Weatherford International, RPM International And Other Big Stocks Moving Higher On Wednesday
benzinga_article·Jul 22 at 09:04 AM
EFOR+4.66%CBRS-5.28%
U.S. stock market update: ArrowHead Pharma rises over 21%, new drug news ignites market enthusiasm
Price Alert·Jul 22 at 09:02 AM
ARWR-8.00%
Arrowhead Pharmaceuticals soars 20% as plozasiran hits Phase 3 endpoints
US Stock Market Update·Jul 22 at 08:40 AM
ARWR-8.00%